EurekAlert! -
13 Jul 2020 06:00
(American Association for the Advancement of Science) By studying fifty COVID-19 patients, researchers in France identified a unique signature - a combination of deficiency in a response of a particular interferon, as well as exacerbated inflammation - in the most critically ill.
Share this Article